Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02466308 · ClinicalTrials.gov registry record · NA
Long Duration Therapeutic Ultrasound for Tendon Healing
A NA study of Tendinopathy and Tendinosis, sponsored by ZetrOZ.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT02466308: Completed NA study of Tendinopathy and Tendinosis, sponsored by ZetrOZ.
NCT02466308 is a NA study of Tendinopathy and Tendinosis that has completed, run by ZetrOZ. The registered enrollment target is 28 participants, below the 1,064-participant average among 10 other Tendinopathy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02466308, a NA study of Tendinopathy and Tendinosis, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
ZetrOZ's Ultrasonic Diathermy device (sam(R) Professional System) is intended for use as a portable and wearable medical device which, when applied to various areas of the body applies Low Intensity Therapeutic Ultrasound (LITUS) to deep tissues. This device is FDA-cleared for pain reduction, treatment of muscle spasm and joint contracture, and increasing local circulation. This study will look at the use of therapeutic ultrasound to relieve pain and enhance tendon extensibility for individuals with tendinopathy over a 6 week time period.
Conditions Studied
Interventions
- DEVICE SAM Ultrasound Diathermy Device
Study Locations (1)
Connecticut
- ZetrOZ, Inc. - Trumbull
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT02466308 record still lists
NCT02466308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,064-participant average among 10 other Tendinopathy trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Tendinopathy appearing as the primary indexed condition, and to 1 intervention - of which SAM Ultrasound Diathermy Device is the first listed.
NCT02466308 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02466308 about?
NCT02466308 is a clinical study titled "Long Duration Therapeutic Ultrasound for Tendon Healing". ZetrOZ's Ultrasonic Diathermy device (sam(R) Professional System) is intended for use as a portable and wearable medical device which, when applied to various areas of the body applies Low Intensity Therapeutic Ultrasound (LITUS) to deep tissues. This device is FDA-cleared for pain reduction, treatm...
What is the current status of trial NCT02466308?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-02. Estimated completion is 2014-09.
What conditions does trial NCT02466308 study?
This clinical trial studies the following conditions: Tendinopathy, Tendinosis, Tendinitis.
What interventions are being tested in trial NCT02466308?
The interventions under investigation include: SAM Ultrasound Diathermy Device (DEVICE).
Who is sponsoring clinical trial NCT02466308?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02466308 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tendinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02466308's enrollment target sits among peer trials
28 9th of 10 higher than 2 of 10 other Tendinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tendinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platelet Rich Plasma for Musculoskeletal Conditions
RECRUITING · NA
-
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
RECRUITING · NA
-
PRP vs PRP Plus IGF for Patellar Tendinosis
COMPLETED · NA
-
Achilles Tendon Repair With Bioinductive Implant
COMPLETED · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
Assessing the Tendons With Shear Wave Elastography
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia